nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—IRAK1—rheumatoid arthritis	0.408	0.635	CbGaD
Ruxolitinib—TYK2—rheumatoid arthritis	0.234	0.365	CbGaD
Ruxolitinib—Tuberculosis—Leflunomide—rheumatoid arthritis	0.00391	0.0532	CcSEcCtD
Ruxolitinib—BMP2K—synovial membrane of synovial joint—rheumatoid arthritis	0.00369	0.0528	CbGeAlD
Ruxolitinib—Tuberculosis—Dexamethasone—rheumatoid arthritis	0.00229	0.0312	CcSEcCtD
Ruxolitinib—Tuberculosis—Betamethasone—rheumatoid arthritis	0.00229	0.0312	CcSEcCtD
Ruxolitinib—Tuberculosis—Prednisone—rheumatoid arthritis	0.002	0.0271	CcSEcCtD
Ruxolitinib—PLK1—Calcipotriol—Ergocalciferol—rheumatoid arthritis	0.00195	1	CbGdCrCtD
Ruxolitinib—Myelosuppression—Azathioprine—rheumatoid arthritis	0.00161	0.0219	CcSEcCtD
Ruxolitinib—PRKG2—digestive system—rheumatoid arthritis	0.00136	0.0195	CbGeAlD
Ruxolitinib—PLK1—lymphoid tissue—rheumatoid arthritis	0.00124	0.0177	CbGeAlD
Ruxolitinib—JAK1—parotid gland—rheumatoid arthritis	0.00123	0.0176	CbGeAlD
Ruxolitinib—PLK1—digestive system—rheumatoid arthritis	0.00122	0.0175	CbGeAlD
Ruxolitinib—PRKCE—tendon—rheumatoid arthritis	0.00121	0.0174	CbGeAlD
Ruxolitinib—JAK1—saliva-secreting gland—rheumatoid arthritis	0.00118	0.0169	CbGeAlD
Ruxolitinib—DAPK2—parotid gland—rheumatoid arthritis	0.00117	0.0168	CbGeAlD
Ruxolitinib—RPS6KA6—tendon—rheumatoid arthritis	0.00116	0.0167	CbGeAlD
Ruxolitinib—Gastrointestinal haemorrhage—Auranofin—rheumatoid arthritis	0.00114	0.0155	CcSEcCtD
Ruxolitinib—DAPK2—saliva-secreting gland—rheumatoid arthritis	0.00113	0.0161	CbGeAlD
Ruxolitinib—Weight decreased—Ergocalciferol—rheumatoid arthritis	0.0011	0.0149	CcSEcCtD
Ruxolitinib—CLK2—parotid gland—rheumatoid arthritis	0.00109	0.0157	CbGeAlD
Ruxolitinib—JAK3—connective tissue—rheumatoid arthritis	0.00109	0.0156	CbGeAlD
Ruxolitinib—JAK1—connective tissue—rheumatoid arthritis	0.00108	0.0155	CbGeAlD
Ruxolitinib—CLK2—saliva-secreting gland—rheumatoid arthritis	0.00105	0.015	CbGeAlD
Ruxolitinib—Night sweats—Cyclosporine—rheumatoid arthritis	0.00102	0.0139	CcSEcCtD
Ruxolitinib—HIPK2—connective tissue—rheumatoid arthritis	0.00101	0.0145	CbGeAlD
Ruxolitinib—Herpes zoster—Azathioprine—rheumatoid arthritis	0.001	0.0137	CcSEcCtD
Ruxolitinib—NUAK2—parotid gland—rheumatoid arthritis	0.000984	0.0141	CbGeAlD
Ruxolitinib—Herpes zoster—Leflunomide—rheumatoid arthritis	0.000948	0.0129	CcSEcCtD
Ruxolitinib—NUAK2—saliva-secreting gland—rheumatoid arthritis	0.000943	0.0135	CbGeAlD
Ruxolitinib—Pancytopenia—Auranofin—rheumatoid arthritis	0.000937	0.0127	CcSEcCtD
Ruxolitinib—ROCK1—connective tissue—rheumatoid arthritis	0.000933	0.0134	CbGeAlD
Ruxolitinib—MARK2—digestive system—rheumatoid arthritis	0.000926	0.0133	CbGeAlD
Ruxolitinib—Neutropenia—Auranofin—rheumatoid arthritis	0.000923	0.0126	CcSEcCtD
Ruxolitinib—CAMK1—tendon—rheumatoid arthritis	0.000908	0.013	CbGeAlD
Ruxolitinib—BMPR2—connective tissue—rheumatoid arthritis	0.000906	0.013	CbGeAlD
Ruxolitinib—Weight decreased—Auranofin—rheumatoid arthritis	0.000893	0.0121	CcSEcCtD
Ruxolitinib—MARK2—tendon—rheumatoid arthritis	0.000882	0.0126	CbGeAlD
Ruxolitinib—Pancytopenia—Penicillamine—rheumatoid arthritis	0.000866	0.0118	CcSEcCtD
Ruxolitinib—Haematuria—Auranofin—rheumatoid arthritis	0.000839	0.0114	CcSEcCtD
Ruxolitinib—MAP3K7—parotid gland—rheumatoid arthritis	0.000829	0.0119	CbGeAlD
Ruxolitinib—Contusion—Leflunomide—rheumatoid arthritis	0.000819	0.0111	CcSEcCtD
Ruxolitinib—TAOK2—tendon—rheumatoid arthritis	0.000816	0.0117	CbGeAlD
Ruxolitinib—TYK2—parotid gland—rheumatoid arthritis	0.000814	0.0117	CbGeAlD
Ruxolitinib—BMP2K—connective tissue—rheumatoid arthritis	0.000811	0.0116	CbGeAlD
Ruxolitinib—MKNK2—parotid gland—rheumatoid arthritis	0.000804	0.0115	CbGeAlD
Ruxolitinib—JAK3—lymphoid tissue—rheumatoid arthritis	0.000797	0.0114	CbGeAlD
Ruxolitinib—MAP3K7—saliva-secreting gland—rheumatoid arthritis	0.000794	0.0114	CbGeAlD
Ruxolitinib—JAK1—lymphoid tissue—rheumatoid arthritis	0.000792	0.0114	CbGeAlD
Ruxolitinib—JAK3—digestive system—rheumatoid arthritis	0.000788	0.0113	CbGeAlD
Ruxolitinib—PLK4—lymphoid tissue—rheumatoid arthritis	0.000787	0.0113	CbGeAlD
Ruxolitinib—JAK1—digestive system—rheumatoid arthritis	0.000783	0.0112	CbGeAlD
Ruxolitinib—DCLK1—digestive system—rheumatoid arthritis	0.000783	0.0112	CbGeAlD
Ruxolitinib—TYK2—saliva-secreting gland—rheumatoid arthritis	0.00078	0.0112	CbGeAlD
Ruxolitinib—Anaemia—Ergocalciferol—rheumatoid arthritis	0.00078	0.0106	CcSEcCtD
Ruxolitinib—Haematuria—Penicillamine—rheumatoid arthritis	0.000775	0.0105	CcSEcCtD
Ruxolitinib—MKNK2—saliva-secreting gland—rheumatoid arthritis	0.00077	0.011	CbGeAlD
Ruxolitinib—Hepatobiliary disease—Penicillamine—rheumatoid arthritis	0.000769	0.0105	CcSEcCtD
Ruxolitinib—Bone pain—Leflunomide—rheumatoid arthritis	0.000746	0.0101	CcSEcCtD
Ruxolitinib—JAK1—tendon—rheumatoid arthritis	0.000745	0.0107	CbGeAlD
Ruxolitinib—DCLK1—tendon—rheumatoid arthritis	0.000745	0.0107	CbGeAlD
Ruxolitinib—STK16—lymphoid tissue—rheumatoid arthritis	0.000744	0.0107	CbGeAlD
Ruxolitinib—HIPK2—lymphoid tissue—rheumatoid arthritis	0.00074	0.0106	CbGeAlD
Ruxolitinib—MAP3K2—connective tissue—rheumatoid arthritis	0.000737	0.0106	CbGeAlD
Ruxolitinib—STK16—digestive system—rheumatoid arthritis	0.000735	0.0105	CbGeAlD
Ruxolitinib—Haemoglobin—Penicillamine—rheumatoid arthritis	0.000733	0.00997	CcSEcCtD
Ruxolitinib—Herpes zoster—Cyclosporine—rheumatoid arthritis	0.000732	0.00995	CcSEcCtD
Ruxolitinib—HIPK2—digestive system—rheumatoid arthritis	0.000731	0.0105	CbGeAlD
Ruxolitinib—Haemorrhage—Penicillamine—rheumatoid arthritis	0.00073	0.00992	CcSEcCtD
Ruxolitinib—CAMK1D—tendon—rheumatoid arthritis	0.000727	0.0104	CbGeAlD
Ruxolitinib—PHKG2—tendon—rheumatoid arthritis	0.000723	0.0104	CbGeAlD
Ruxolitinib—TYK2—connective tissue—rheumatoid arthritis	0.000717	0.0103	CbGeAlD
Ruxolitinib—MAP3K3—parotid gland—rheumatoid arthritis	0.000714	0.0102	CbGeAlD
Ruxolitinib—DAPK2—tendon—rheumatoid arthritis	0.000711	0.0102	CbGeAlD
Ruxolitinib—MKNK2—connective tissue—rheumatoid arthritis	0.000707	0.0101	CbGeAlD
Ruxolitinib—CLK2—lymphoid tissue—rheumatoid arthritis	0.000704	0.0101	CbGeAlD
Ruxolitinib—STK16—tendon—rheumatoid arthritis	0.000699	0.01	CbGeAlD
Ruxolitinib—HIPK2—tendon—rheumatoid arthritis	0.000695	0.00997	CbGeAlD
Ruxolitinib—RET—connective tissue—rheumatoid arthritis	0.00069	0.00989	CbGeAlD
Ruxolitinib—MAP3K3—saliva-secreting gland—rheumatoid arthritis	0.000684	0.0098	CbGeAlD
Ruxolitinib—ROCK1—lymphoid tissue—rheumatoid arthritis	0.000682	0.00978	CbGeAlD
Ruxolitinib—Flatulence—Auranofin—rheumatoid arthritis	0.000678	0.00922	CcSEcCtD
Ruxolitinib—ROCK1—digestive system—rheumatoid arthritis	0.000674	0.00966	CbGeAlD
Ruxolitinib—DAPK3—tendon—rheumatoid arthritis	0.000668	0.00957	CbGeAlD
Ruxolitinib—DYRK1A—lymphoid tissue—rheumatoid arthritis	0.000665	0.00954	CbGeAlD
Ruxolitinib—BMPR2—lymphoid tissue—rheumatoid arthritis	0.000663	0.0095	CbGeAlD
Ruxolitinib—CLK2—tendon—rheumatoid arthritis	0.000662	0.00949	CbGeAlD
Ruxolitinib—BMPR2—digestive system—rheumatoid arthritis	0.000655	0.00938	CbGeAlD
Ruxolitinib—JAK2—connective tissue—rheumatoid arthritis	0.000652	0.00934	CbGeAlD
Ruxolitinib—TAOK3—parotid gland—rheumatoid arthritis	0.000651	0.00933	CbGeAlD
Ruxolitinib—Anaemia—Auranofin—rheumatoid arthritis	0.000636	0.00864	CcSEcCtD
Ruxolitinib—TAOK3—saliva-secreting gland—rheumatoid arthritis	0.000623	0.00893	CbGeAlD
Ruxolitinib—BMPR2—tendon—rheumatoid arthritis	0.000623	0.00893	CbGeAlD
Ruxolitinib—Anaemia—Penicillamine—rheumatoid arthritis	0.000587	0.00798	CcSEcCtD
Ruxolitinib—CAMK2G—digestive system—rheumatoid arthritis	0.000586	0.0084	CbGeAlD
Ruxolitinib—TAOK3—connective tissue—rheumatoid arthritis	0.000573	0.00821	CbGeAlD
Ruxolitinib—Contusion—Hydrocortisone—rheumatoid arthritis	0.000561	0.00764	CcSEcCtD
Ruxolitinib—BMP2K—tendon—rheumatoid arthritis	0.000558	0.00799	CbGeAlD
Ruxolitinib—CAMK2G—tendon—rheumatoid arthritis	0.000558	0.00799	CbGeAlD
Ruxolitinib—LRRK2—tendon—rheumatoid arthritis	0.000553	0.00792	CbGeAlD
Ruxolitinib—Thrombocytopenia—Auranofin—rheumatoid arthritis	0.000549	0.00747	CcSEcCtD
Ruxolitinib—MAP3K2—lymphoid tissue—rheumatoid arthritis	0.000539	0.00772	CbGeAlD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Penicillamine—rheumatoid arthritis	0.000537	0.0073	CcSEcCtD
Ruxolitinib—TYK2—lymphoid tissue—rheumatoid arthritis	0.000524	0.00751	CbGeAlD
Ruxolitinib—TYK2—digestive system—rheumatoid arthritis	0.000518	0.00742	CbGeAlD
Ruxolitinib—MKNK2—lymphoid tissue—rheumatoid arthritis	0.000517	0.00741	CbGeAlD
Ruxolitinib—MKNK2—digestive system—rheumatoid arthritis	0.000511	0.00732	CbGeAlD
Ruxolitinib—Thrombocytopenia—Penicillamine—rheumatoid arthritis	0.000507	0.0069	CcSEcCtD
Ruxolitinib—RET—lymphoid tissue—rheumatoid arthritis	0.000504	0.00723	CbGeAlD
Ruxolitinib—Skin disorder—Penicillamine—rheumatoid arthritis	0.000503	0.00685	CcSEcCtD
Ruxolitinib—MAP3K7—tendon—rheumatoid arthritis	0.000502	0.00719	CbGeAlD
Ruxolitinib—RET—digestive system—rheumatoid arthritis	0.000498	0.00714	CbGeAlD
Ruxolitinib—Asthenia—Ergocalciferol—rheumatoid arthritis	0.000494	0.00672	CcSEcCtD
Ruxolitinib—TYK2—tendon—rheumatoid arthritis	0.000493	0.00706	CbGeAlD
Ruxolitinib—MKNK2—tendon—rheumatoid arthritis	0.000486	0.00697	CbGeAlD
Ruxolitinib—IRAK1—tendon—rheumatoid arthritis	0.000486	0.00697	CbGeAlD
Ruxolitinib—Contusion—Dexamethasone—rheumatoid arthritis	0.00048	0.00652	CcSEcCtD
Ruxolitinib—Contusion—Betamethasone—rheumatoid arthritis	0.00048	0.00652	CcSEcCtD
Ruxolitinib—JAK2—lymphoid tissue—rheumatoid arthritis	0.000477	0.00683	CbGeAlD
Ruxolitinib—RET—tendon—rheumatoid arthritis	0.000474	0.00679	CbGeAlD
Ruxolitinib—JAK2—digestive system—rheumatoid arthritis	0.000471	0.00675	CbGeAlD
Ruxolitinib—Pancytopenia—Azathioprine—rheumatoid arthritis	0.000451	0.00613	CcSEcCtD
Ruxolitinib—JAK2—tendon—rheumatoid arthritis	0.000448	0.00642	CbGeAlD
Ruxolitinib—MAP3K3—tendon—rheumatoid arthritis	0.000432	0.00619	CbGeAlD
Ruxolitinib—Pancytopenia—Leflunomide—rheumatoid arthritis	0.000426	0.00579	CcSEcCtD
Ruxolitinib—Infestation NOS—Azathioprine—rheumatoid arthritis	0.000423	0.00575	CcSEcCtD
Ruxolitinib—Infestation—Azathioprine—rheumatoid arthritis	0.000423	0.00575	CcSEcCtD
Ruxolitinib—Neutropenia—Leflunomide—rheumatoid arthritis	0.000419	0.0057	CcSEcCtD
Ruxolitinib—TAOK3—lymphoid tissue—rheumatoid arthritis	0.000419	0.006	CbGeAlD
Ruxolitinib—Contusion—Prednisone—rheumatoid arthritis	0.000418	0.00568	CcSEcCtD
Ruxolitinib—TAOK3—digestive system—rheumatoid arthritis	0.000414	0.00593	CbGeAlD
Ruxolitinib—Body temperature increased—Penicillamine—rheumatoid arthritis	0.00041	0.00557	CcSEcCtD
Ruxolitinib—Weight decreased—Leflunomide—rheumatoid arthritis	0.000405	0.00551	CcSEcCtD
Ruxolitinib—Herpes zoster—Methotrexate—rheumatoid arthritis	0.000404	0.0055	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Azathioprine—rheumatoid arthritis	0.0004	0.00544	CcSEcCtD
Ruxolitinib—Infestation—Leflunomide—rheumatoid arthritis	0.000399	0.00543	CcSEcCtD
Ruxolitinib—Infestation NOS—Leflunomide—rheumatoid arthritis	0.000399	0.00543	CcSEcCtD
Ruxolitinib—Pruritus—Auranofin—rheumatoid arthritis	0.000397	0.0054	CcSEcCtD
Ruxolitinib—TAOK3—tendon—rheumatoid arthritis	0.000394	0.00564	CbGeAlD
Ruxolitinib—Urinary tract infection—Leflunomide—rheumatoid arthritis	0.000388	0.00528	CcSEcCtD
Ruxolitinib—Hypercholesterolaemia—Prednisone—rheumatoid arthritis	0.000385	0.00524	CcSEcCtD
Ruxolitinib—Haemoglobin—Azathioprine—rheumatoid arthritis	0.000382	0.00519	CcSEcCtD
Ruxolitinib—Haematuria—Leflunomide—rheumatoid arthritis	0.000381	0.00518	CcSEcCtD
Ruxolitinib—Haemorrhage—Azathioprine—rheumatoid arthritis	0.00038	0.00516	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Leflunomide—rheumatoid arthritis	0.000378	0.00514	CcSEcCtD
Ruxolitinib—Epistaxis—Leflunomide—rheumatoid arthritis	0.000377	0.00512	CcSEcCtD
Ruxolitinib—Haemoglobin—Leflunomide—rheumatoid arthritis	0.00036	0.0049	CcSEcCtD
Ruxolitinib—Haemorrhage—Leflunomide—rheumatoid arthritis	0.000359	0.00488	CcSEcCtD
Ruxolitinib—Weight increased—Cyclosporine—rheumatoid arthritis	0.000315	0.00428	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Hydrocortisone—rheumatoid arthritis	0.000314	0.00427	CcSEcCtD
Ruxolitinib—Weight decreased—Cyclosporine—rheumatoid arthritis	0.000313	0.00425	CcSEcCtD
Ruxolitinib—Malnutrition—Leflunomide—rheumatoid arthritis	0.000312	0.00425	CcSEcCtD
Ruxolitinib—Infestation NOS—Cyclosporine—rheumatoid arthritis	0.000308	0.00419	CcSEcCtD
Ruxolitinib—Infestation—Cyclosporine—rheumatoid arthritis	0.000308	0.00419	CcSEcCtD
Ruxolitinib—Flatulence—Leflunomide—rheumatoid arthritis	0.000308	0.00418	CcSEcCtD
Ruxolitinib—Anaemia—Azathioprine—rheumatoid arthritis	0.000306	0.00416	CcSEcCtD
Ruxolitinib—Urinary tract infection—Cyclosporine—rheumatoid arthritis	0.0003	0.00408	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Methylprednisolone—rheumatoid arthritis	0.000295	0.00401	CcSEcCtD
Ruxolitinib—Haematuria—Cyclosporine—rheumatoid arthritis	0.000294	0.004	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Cyclosporine—rheumatoid arthritis	0.000292	0.00397	CcSEcCtD
Ruxolitinib—Epistaxis—Cyclosporine—rheumatoid arthritis	0.000291	0.00396	CcSEcCtD
Ruxolitinib—Anaemia—Leflunomide—rheumatoid arthritis	0.000289	0.00392	CcSEcCtD
Ruxolitinib—Weight increased—Prednisolone—rheumatoid arthritis	0.000286	0.00389	CcSEcCtD
Ruxolitinib—Weight increased—Hydrocortisone—rheumatoid arthritis	0.00028	0.0038	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—rheumatoid arthritis	0.00028	0.0038	CcSEcCtD
Ruxolitinib—Haemoglobin—Cyclosporine—rheumatoid arthritis	0.000278	0.00378	CcSEcCtD
Ruxolitinib—Weight decreased—Hydrocortisone—rheumatoid arthritis	0.000278	0.00378	CcSEcCtD
Ruxolitinib—Haemorrhage—Cyclosporine—rheumatoid arthritis	0.000277	0.00376	CcSEcCtD
Ruxolitinib—Infestation NOS—Hydrocortisone—rheumatoid arthritis	0.000274	0.00373	CcSEcCtD
Ruxolitinib—Infestation—Hydrocortisone—rheumatoid arthritis	0.000274	0.00373	CcSEcCtD
Ruxolitinib—Infection—Azathioprine—rheumatoid arthritis	0.000268	0.00365	CcSEcCtD
Ruxolitinib—Gastrointestinal haemorrhage—Prednisone—rheumatoid arthritis	0.000265	0.0036	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Azathioprine—rheumatoid arthritis	0.000264	0.00359	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—rheumatoid arthritis	0.000264	0.00359	CcSEcCtD
Ruxolitinib—Weight increased—Triamcinolone—rheumatoid arthritis	0.000263	0.00358	CcSEcCtD
Ruxolitinib—Weight increased—Methylprednisolone—rheumatoid arthritis	0.000263	0.00357	CcSEcCtD
Ruxolitinib—Skin disorder—Azathioprine—rheumatoid arthritis	0.000262	0.00356	CcSEcCtD
Ruxolitinib—Infestation NOS—Methylprednisolone—rheumatoid arthritis	0.000257	0.0035	CcSEcCtD
Ruxolitinib—Infestation—Methylprednisolone—rheumatoid arthritis	0.000257	0.0035	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisolone—rheumatoid arthritis	0.000253	0.00344	CcSEcCtD
Ruxolitinib—Infection—Leflunomide—rheumatoid arthritis	0.000253	0.00344	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisolone—rheumatoid arthritis	0.000252	0.00343	CcSEcCtD
Ruxolitinib—Nervous system disorder—Leflunomide—rheumatoid arthritis	0.00025	0.0034	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Leflunomide—rheumatoid arthritis	0.000249	0.00339	CcSEcCtD
Ruxolitinib—Skin disorder—Leflunomide—rheumatoid arthritis	0.000247	0.00337	CcSEcCtD
Ruxolitinib—Haemoglobin—Hydrocortisone—rheumatoid arthritis	0.000247	0.00336	CcSEcCtD
Ruxolitinib—Haemorrhage—Hydrocortisone—rheumatoid arthritis	0.000246	0.00335	CcSEcCtD
Ruxolitinib—Epistaxis—Triamcinolone—rheumatoid arthritis	0.000243	0.00331	CcSEcCtD
Ruxolitinib—Malnutrition—Cyclosporine—rheumatoid arthritis	0.000241	0.00328	CcSEcCtD
Ruxolitinib—Weight increased—Betamethasone—rheumatoid arthritis	0.000239	0.00325	CcSEcCtD
Ruxolitinib—Weight increased—Dexamethasone—rheumatoid arthritis	0.000239	0.00325	CcSEcCtD
Ruxolitinib—Weight decreased—Dexamethasone—rheumatoid arthritis	0.000238	0.00323	CcSEcCtD
Ruxolitinib—Weight decreased—Betamethasone—rheumatoid arthritis	0.000238	0.00323	CcSEcCtD
Ruxolitinib—Flatulence—Cyclosporine—rheumatoid arthritis	0.000237	0.00323	CcSEcCtD
Ruxolitinib—Alanine aminotransferase increased—Prednisone—rheumatoid arthritis	0.000233	0.00317	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Azathioprine—rheumatoid arthritis	0.000233	0.00317	CcSEcCtD
Ruxolitinib—Haemoglobin—Triamcinolone—rheumatoid arthritis	0.000233	0.00317	CcSEcCtD
Ruxolitinib—Haemoglobin—Methylprednisolone—rheumatoid arthritis	0.000232	0.00316	CcSEcCtD
Ruxolitinib—Haemorrhage—Triamcinolone—rheumatoid arthritis	0.000232	0.00315	CcSEcCtD
Ruxolitinib—Haemorrhage—Methylprednisolone—rheumatoid arthritis	0.000231	0.00314	CcSEcCtD
Ruxolitinib—Anaemia—Cyclosporine—rheumatoid arthritis	0.000223	0.00303	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Leflunomide—rheumatoid arthritis	0.00022	0.00299	CcSEcCtD
Ruxolitinib—Fatigue—Leflunomide—rheumatoid arthritis	0.00022	0.00299	CcSEcCtD
Ruxolitinib—Malnutrition—Hydrocortisone—rheumatoid arthritis	0.000214	0.00291	CcSEcCtD
Ruxolitinib—Neutropenia—Prednisone—rheumatoid arthritis	0.000214	0.00291	CcSEcCtD
Ruxolitinib—Body temperature increased—Azathioprine—rheumatoid arthritis	0.000213	0.0029	CcSEcCtD
Ruxolitinib—Haemoglobin—Betamethasone—rheumatoid arthritis	0.000211	0.00287	CcSEcCtD
Ruxolitinib—Haemoglobin—Dexamethasone—rheumatoid arthritis	0.000211	0.00287	CcSEcCtD
Ruxolitinib—Haemorrhage—Betamethasone—rheumatoid arthritis	0.00021	0.00286	CcSEcCtD
Ruxolitinib—Haemorrhage—Dexamethasone—rheumatoid arthritis	0.00021	0.00286	CcSEcCtD
Ruxolitinib—Weight increased—Prednisone—rheumatoid arthritis	0.000208	0.00283	CcSEcCtD
Ruxolitinib—Weight decreased—Prednisone—rheumatoid arthritis	0.000207	0.00281	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000204	0.00277	CcSEcCtD
Ruxolitinib—Body temperature increased—Leflunomide—rheumatoid arthritis	0.000201	0.00274	CcSEcCtD
Ruxolitinib—Malnutrition—Methylprednisolone—rheumatoid arthritis	0.000201	0.00274	CcSEcCtD
Ruxolitinib—Infection—Cyclosporine—rheumatoid arthritis	0.000195	0.00266	CcSEcCtD
Ruxolitinib—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000193	0.00262	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000193	0.00262	CcSEcCtD
Ruxolitinib—Skin disorder—Cyclosporine—rheumatoid arthritis	0.000191	0.0026	CcSEcCtD
Ruxolitinib—Haemoglobin—Prednisone—rheumatoid arthritis	0.000184	0.0025	CcSEcCtD
Ruxolitinib—Haemorrhage—Prednisone—rheumatoid arthritis	0.000183	0.00249	CcSEcCtD
Ruxolitinib—Asthenia—Leflunomide—rheumatoid arthritis	0.000183	0.00249	CcSEcCtD
Ruxolitinib—Pancytopenia—Methotrexate—rheumatoid arthritis	0.000181	0.00247	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000181	0.00246	CcSEcCtD
Ruxolitinib—Pruritus—Leflunomide—rheumatoid arthritis	0.00018	0.00245	CcSEcCtD
Ruxolitinib—Neutropenia—Methotrexate—rheumatoid arthritis	0.000179	0.00243	CcSEcCtD
Ruxolitinib—Dizziness—Azathioprine—rheumatoid arthritis	0.000178	0.00243	CcSEcCtD
Ruxolitinib—Infection—Hydrocortisone—rheumatoid arthritis	0.000174	0.00236	CcSEcCtD
Ruxolitinib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000171	0.00233	CcSEcCtD
Ruxolitinib—Infestation NOS—Methotrexate—rheumatoid arthritis	0.00017	0.00232	CcSEcCtD
Ruxolitinib—Infestation—Methotrexate—rheumatoid arthritis	0.00017	0.00232	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.00017	0.00231	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00017	0.00231	CcSEcCtD
Ruxolitinib—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.00017	0.00231	CcSEcCtD
Ruxolitinib—Fatigue—Cyclosporine—rheumatoid arthritis	0.00017	0.00231	CcSEcCtD
Ruxolitinib—Headache—Azathioprine—rheumatoid arthritis	0.000169	0.0023	CcSEcCtD
Ruxolitinib—Dizziness—Leflunomide—rheumatoid arthritis	0.000168	0.00229	CcSEcCtD
Ruxolitinib—Infection—Triamcinolone—rheumatoid arthritis	0.000163	0.00222	CcSEcCtD
Ruxolitinib—Infection—Methylprednisolone—rheumatoid arthritis	0.000163	0.00222	CcSEcCtD
Ruxolitinib—Haematuria—Methotrexate—rheumatoid arthritis	0.000162	0.00221	CcSEcCtD
Ruxolitinib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000161	0.00219	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000161	0.00219	CcSEcCtD
Ruxolitinib—Epistaxis—Methotrexate—rheumatoid arthritis	0.000161	0.00219	CcSEcCtD
Ruxolitinib—Headache—Leflunomide—rheumatoid arthritis	0.00016	0.00217	CcSEcCtD
Ruxolitinib—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000159	0.00217	CcSEcCtD
Ruxolitinib—Malnutrition—Prednisone—rheumatoid arthritis	0.000159	0.00217	CcSEcCtD
Ruxolitinib—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000155	0.00211	CcSEcCtD
Ruxolitinib—Haemoglobin—Methotrexate—rheumatoid arthritis	0.000154	0.00209	CcSEcCtD
Ruxolitinib—Haemorrhage—Methotrexate—rheumatoid arthritis	0.000153	0.00208	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000151	0.00205	CcSEcCtD
Ruxolitinib—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000151	0.00205	CcSEcCtD
Ruxolitinib—Infection—Dexamethasone—rheumatoid arthritis	0.000148	0.00202	CcSEcCtD
Ruxolitinib—Infection—Betamethasone—rheumatoid arthritis	0.000148	0.00202	CcSEcCtD
Ruxolitinib—Anaemia—Prednisone—rheumatoid arthritis	0.000147	0.002	CcSEcCtD
Ruxolitinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000146	0.00199	CcSEcCtD
Ruxolitinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000146	0.00199	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000146	0.00199	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000146	0.00199	CcSEcCtD
Ruxolitinib—Fatigue—Triamcinolone—rheumatoid arthritis	0.000142	0.00193	CcSEcCtD
Ruxolitinib—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000142	0.00193	CcSEcCtD
Ruxolitinib—Asthenia—Cyclosporine—rheumatoid arthritis	0.000141	0.00192	CcSEcCtD
Ruxolitinib—Pruritus—Cyclosporine—rheumatoid arthritis	0.000139	0.00189	CcSEcCtD
Ruxolitinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000138	0.00188	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000135	0.00183	CcSEcCtD
Ruxolitinib—Malnutrition—Methotrexate—rheumatoid arthritis	0.000133	0.00181	CcSEcCtD
Ruxolitinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.00013	0.00177	CcSEcCtD
Ruxolitinib—Dizziness—Cyclosporine—rheumatoid arthritis	0.00013	0.00177	CcSEcCtD
Ruxolitinib—Infection—Prednisone—rheumatoid arthritis	0.000129	0.00176	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000129	0.00175	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000129	0.00175	CcSEcCtD
Ruxolitinib—Fatigue—Betamethasone—rheumatoid arthritis	0.000129	0.00175	CcSEcCtD
Ruxolitinib—Fatigue—Dexamethasone—rheumatoid arthritis	0.000129	0.00175	CcSEcCtD
Ruxolitinib—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000128	0.00173	CcSEcCtD
Ruxolitinib—Skin disorder—Prednisone—rheumatoid arthritis	0.000126	0.00172	CcSEcCtD
Ruxolitinib—CYP3A4—digestive system—rheumatoid arthritis	0.000126	0.0018	CbGeAlD
Ruxolitinib—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000125	0.00171	CcSEcCtD
Ruxolitinib—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000124	0.00168	CcSEcCtD
Ruxolitinib—Headache—Cyclosporine—rheumatoid arthritis	0.000123	0.00168	CcSEcCtD
Ruxolitinib—Anaemia—Methotrexate—rheumatoid arthritis	0.000123	0.00167	CcSEcCtD
Ruxolitinib—Dizziness—Prednisolone—rheumatoid arthritis	0.000118	0.00161	CcSEcCtD
Ruxolitinib—Asthenia—Triamcinolone—rheumatoid arthritis	0.000118	0.00161	CcSEcCtD
Ruxolitinib—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000118	0.00161	CcSEcCtD
Ruxolitinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000118	0.00161	CcSEcCtD
Ruxolitinib—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000118	0.0016	CcSEcCtD
Ruxolitinib—Pruritus—Triamcinolone—rheumatoid arthritis	0.000116	0.00158	CcSEcCtD
Ruxolitinib—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000116	0.00158	CcSEcCtD
Ruxolitinib—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000116	0.00157	CcSEcCtD
Ruxolitinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000113	0.00153	CcSEcCtD
Ruxolitinib—Fatigue—Prednisone—rheumatoid arthritis	0.000112	0.00152	CcSEcCtD
Ruxolitinib—Headache—Prednisolone—rheumatoid arthritis	0.000112	0.00152	CcSEcCtD
Ruxolitinib—Headache—Hydrocortisone—rheumatoid arthritis	0.000109	0.00149	CcSEcCtD
Ruxolitinib—Dizziness—Triamcinolone—rheumatoid arthritis	0.000109	0.00148	CcSEcCtD
Ruxolitinib—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000109	0.00148	CcSEcCtD
Ruxolitinib—Infection—Methotrexate—rheumatoid arthritis	0.000108	0.00147	CcSEcCtD
Ruxolitinib—Asthenia—Dexamethasone—rheumatoid arthritis	0.000107	0.00146	CcSEcCtD
Ruxolitinib—Asthenia—Betamethasone—rheumatoid arthritis	0.000107	0.00146	CcSEcCtD
Ruxolitinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000107	0.00145	CcSEcCtD
Ruxolitinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000106	0.00145	CcSEcCtD
Ruxolitinib—Pruritus—Dexamethasone—rheumatoid arthritis	0.000106	0.00144	CcSEcCtD
Ruxolitinib—Pruritus—Betamethasone—rheumatoid arthritis	0.000106	0.00144	CcSEcCtD
Ruxolitinib—Skin disorder—Methotrexate—rheumatoid arthritis	0.000106	0.00144	CcSEcCtD
Ruxolitinib—Headache—Triamcinolone—rheumatoid arthritis	0.000103	0.0014	CcSEcCtD
Ruxolitinib—Headache—Methylprednisolone—rheumatoid arthritis	0.000103	0.0014	CcSEcCtD
Ruxolitinib—Body temperature increased—Prednisone—rheumatoid arthritis	0.000103	0.0014	CcSEcCtD
Ruxolitinib—Dizziness—Dexamethasone—rheumatoid arthritis	9.87e-05	0.00134	CcSEcCtD
Ruxolitinib—Dizziness—Betamethasone—rheumatoid arthritis	9.87e-05	0.00134	CcSEcCtD
Ruxolitinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	9.38e-05	0.00128	CcSEcCtD
Ruxolitinib—Fatigue—Methotrexate—rheumatoid arthritis	9.37e-05	0.00127	CcSEcCtD
Ruxolitinib—Headache—Betamethasone—rheumatoid arthritis	9.35e-05	0.00127	CcSEcCtD
Ruxolitinib—Headache—Dexamethasone—rheumatoid arthritis	9.35e-05	0.00127	CcSEcCtD
Ruxolitinib—Asthenia—Prednisone—rheumatoid arthritis	9.33e-05	0.00127	CcSEcCtD
Ruxolitinib—Pruritus—Prednisone—rheumatoid arthritis	9.2e-05	0.00125	CcSEcCtD
Ruxolitinib—Dizziness—Prednisone—rheumatoid arthritis	8.6e-05	0.00117	CcSEcCtD
Ruxolitinib—Body temperature increased—Methotrexate—rheumatoid arthritis	8.59e-05	0.00117	CcSEcCtD
Ruxolitinib—Headache—Prednisone—rheumatoid arthritis	8.15e-05	0.00111	CcSEcCtD
Ruxolitinib—Asthenia—Methotrexate—rheumatoid arthritis	7.8e-05	0.00106	CcSEcCtD
Ruxolitinib—Pruritus—Methotrexate—rheumatoid arthritis	7.69e-05	0.00105	CcSEcCtD
Ruxolitinib—Dizziness—Methotrexate—rheumatoid arthritis	7.19e-05	0.000977	CcSEcCtD
Ruxolitinib—Headache—Methotrexate—rheumatoid arthritis	6.81e-05	0.000926	CcSEcCtD
Ruxolitinib—JAK3—Signaling Pathways—NOS3—rheumatoid arthritis	2.31e-06	1.09e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—IL6—rheumatoid arthritis	2.31e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—MAPK8—rheumatoid arthritis	2.3e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TP53—rheumatoid arthritis	2.29e-06	1.08e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CSF2—rheumatoid arthritis	2.28e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SPP1—rheumatoid arthritis	2.28e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—rheumatoid arthritis	2.28e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—MTHFR—rheumatoid arthritis	2.27e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—HLA-A—rheumatoid arthritis	2.27e-06	1.07e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TLR4—rheumatoid arthritis	2.25e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—HLA-DRB1—rheumatoid arthritis	2.24e-06	1.06e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—TYK2—rheumatoid arthritis	2.24e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—rheumatoid arthritis	2.24e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IFNG—rheumatoid arthritis	2.23e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CCL2—rheumatoid arthritis	2.23e-06	1.05e-05	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6R—rheumatoid arthritis	2.22e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RASGRP1—rheumatoid arthritis	2.22e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCR5—rheumatoid arthritis	2.22e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SYK—rheumatoid arthritis	2.21e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SPP1—rheumatoid arthritis	2.21e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TGFB1—rheumatoid arthritis	2.21e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.2e-06	1.04e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—IL6—rheumatoid arthritis	2.2e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MMP9—rheumatoid arthritis	2.19e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CCL2—rheumatoid arthritis	2.19e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6R—rheumatoid arthritis	2.18e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2RA—rheumatoid arthritis	2.18e-06	1.03e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—NFKB1—rheumatoid arthritis	2.17e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRKCQ—rheumatoid arthritis	2.17e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TGFB1—rheumatoid arthritis	2.17e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—C3—rheumatoid arthritis	2.17e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IFNG—rheumatoid arthritis	2.16e-06	1.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—rheumatoid arthritis	2.16e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—ICAM1—rheumatoid arthritis	2.15e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6ST—rheumatoid arthritis	2.15e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CD4—rheumatoid arthritis	2.15e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCR5—rheumatoid arthritis	2.15e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SPP1—rheumatoid arthritis	2.14e-06	1.01e-05	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MAPK8—rheumatoid arthritis	2.13e-06	1e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—STAT1—rheumatoid arthritis	2.13e-06	1e-05	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2RA—rheumatoid arthritis	2.12e-06	9.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CCL2—rheumatoid arthritis	2.11e-06	9.92e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—IL6—rheumatoid arthritis	2.11e-06	9.91e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6R—rheumatoid arthritis	2.1e-06	9.89e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL2—rheumatoid arthritis	2.1e-06	9.89e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL10—rheumatoid arthritis	2.1e-06	9.88e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—C3—rheumatoid arthritis	2.1e-06	9.88e-06	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IL6—rheumatoid arthritis	2.1e-06	9.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IFNG—rheumatoid arthritis	2.1e-06	9.87e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NOS3—rheumatoid arthritis	2.09e-06	9.84e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CD4—rheumatoid arthritis	2.09e-06	9.82e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCR5—rheumatoid arthritis	2.09e-06	9.81e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD80—rheumatoid arthritis	2.07e-06	9.75e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—rheumatoid arthritis	2.06e-06	9.7e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2RA—rheumatoid arthritis	2.06e-06	9.67e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CXCL8—rheumatoid arthritis	2.05e-06	9.63e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—C3—rheumatoid arthritis	2.04e-06	9.59e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CD4—rheumatoid arthritis	2.03e-06	9.53e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TYK2—rheumatoid arthritis	2.02e-06	9.51e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—rheumatoid arthritis	2.02e-06	9.48e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—IL6—rheumatoid arthritis	2e-06	9.4e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TYK2—rheumatoid arthritis	1.99e-06	9.36e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6ST—rheumatoid arthritis	1.99e-06	9.35e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL1B—rheumatoid arthritis	1.99e-06	9.35e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NOS3—rheumatoid arthritis	1.99e-06	9.34e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	1.98e-06	9.32e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL2—rheumatoid arthritis	1.98e-06	9.31e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS2—rheumatoid arthritis	1.97e-06	9.28e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VEGFA—rheumatoid arthritis	1.97e-06	9.27e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—rheumatoid arthritis	1.96e-06	9.2e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL2—rheumatoid arthritis	1.96e-06	9.2e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NOS3—rheumatoid arthritis	1.95e-06	9.18e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—IL6—rheumatoid arthritis	1.95e-06	9.16e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—IL6—rheumatoid arthritis	1.95e-06	9.15e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—IL6—rheumatoid arthritis	1.94e-06	9.12e-06	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—IL6—rheumatoid arthritis	1.93e-06	9.08e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL1B—rheumatoid arthritis	1.93e-06	9.07e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—CD4—rheumatoid arthritis	1.93e-06	9.07e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6R—rheumatoid arthritis	1.92e-06	9.04e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL2—rheumatoid arthritis	1.92e-06	9.04e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP3—rheumatoid arthritis	1.92e-06	9.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TYK2—rheumatoid arthritis	1.92e-06	9.01e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD80—rheumatoid arthritis	1.91e-06	9e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PTGS2—rheumatoid arthritis	1.91e-06	9e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	1.91e-06	9e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FN1—rheumatoid arthritis	1.9e-06	8.94e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—rheumatoid arthritis	1.9e-06	8.92e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.89e-06	8.9e-06	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—IL6—rheumatoid arthritis	1.89e-06	8.87e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—IL6—rheumatoid arthritis	1.88e-06	8.85e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—TGFB1—rheumatoid arthritis	1.88e-06	8.82e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL1B—rheumatoid arthritis	1.87e-06	8.8e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL2—rheumatoid arthritis	1.86e-06	8.77e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—NFKB1—rheumatoid arthritis	1.85e-06	8.72e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MMP9—rheumatoid arthritis	1.85e-06	8.71e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PTK2—rheumatoid arthritis	1.85e-06	8.68e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FN1—rheumatoid arthritis	1.85e-06	8.68e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.84e-06	8.64e-06	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.84e-06	8.64e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.83e-06	8.62e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—MAPK8—rheumatoid arthritis	1.82e-06	8.57e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CD80—rheumatoid arthritis	1.82e-06	8.57e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL5—rheumatoid arthritis	1.81e-06	8.51e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TGFB1—rheumatoid arthritis	1.81e-06	8.5e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.8e-06	8.47e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—NFKB1—rheumatoid arthritis	1.8e-06	8.46e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	1.8e-06	8.46e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FN1—rheumatoid arthritis	1.79e-06	8.42e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—TP53—rheumatoid arthritis	1.78e-06	8.39e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6ST—rheumatoid arthritis	1.78e-06	8.38e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CSF2—rheumatoid arthritis	1.78e-06	8.38e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—IL6—rheumatoid arthritis	1.78e-06	8.37e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6R—rheumatoid arthritis	1.77e-06	8.34e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—MAPK8—rheumatoid arthritis	1.77e-06	8.32e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CD80—rheumatoid arthritis	1.77e-06	8.32e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.76e-06	8.28e-06	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—IL2—rheumatoid arthritis	1.76e-06	8.26e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GC—rheumatoid arthritis	1.75e-06	8.23e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	1.75e-06	8.23e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—TYK2—rheumatoid arthritis	1.75e-06	8.23e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—NFKB1—rheumatoid arthritis	1.75e-06	8.21e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.73e-06	8.15e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—rheumatoid arthritis	1.73e-06	8.14e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—MAPK8—rheumatoid arthritis	1.72e-06	8.07e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CD80—rheumatoid arthritis	1.72e-06	8.07e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CCL2—rheumatoid arthritis	1.69e-06	7.97e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6R—rheumatoid arthritis	1.69e-06	7.94e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL2—rheumatoid arthritis	1.68e-06	7.92e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—rheumatoid arthritis	1.68e-06	7.9e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SPP1—rheumatoid arthritis	1.68e-06	7.88e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—IL6—rheumatoid arthritis	1.67e-06	7.88e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.67e-06	7.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—IL6—rheumatoid arthritis	1.66e-06	7.83e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.66e-06	7.82e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL2—rheumatoid arthritis	1.66e-06	7.79e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—IL6—rheumatoid arthritis	1.65e-06	7.75e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CCL2—rheumatoid arthritis	1.64e-06	7.73e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6R—rheumatoid arthritis	1.64e-06	7.71e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IFNG—rheumatoid arthritis	1.64e-06	7.71e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—rheumatoid arthritis	1.63e-06	7.67e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCR5—rheumatoid arthritis	1.63e-06	7.66e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	1.63e-06	7.65e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TYK2—rheumatoid arthritis	1.62e-06	7.6e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.61e-06	7.55e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CCL2—rheumatoid arthritis	1.6e-06	7.5e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL2—rheumatoid arthritis	1.59e-06	7.5e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MMP9—rheumatoid arthritis	1.59e-06	7.49e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—C3—rheumatoid arthritis	1.59e-06	7.49e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6R—rheumatoid arthritis	1.59e-06	7.48e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NOS3—rheumatoid arthritis	1.59e-06	7.46e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CD4—rheumatoid arthritis	1.58e-06	7.44e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.58e-06	7.41e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MMP9—rheumatoid arthritis	1.57e-06	7.37e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.55e-06	7.29e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.55e-06	7.29e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TYK2—rheumatoid arthritis	1.54e-06	7.23e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—IL6—rheumatoid arthritis	1.53e-06	7.2e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.53e-06	7.18e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.52e-06	7.17e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NOS3—rheumatoid arthritis	1.51e-06	7.1e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TP53—rheumatoid arthritis	1.49e-06	7e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—rheumatoid arthritis	1.48e-06	6.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—IL6—rheumatoid arthritis	1.47e-06	6.91e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NOS3—rheumatoid arthritis	1.47e-06	6.89e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL1B—rheumatoid arthritis	1.46e-06	6.88e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—CD4—rheumatoid arthritis	1.46e-06	6.87e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL2—rheumatoid arthritis	1.46e-06	6.85e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PTGS2—rheumatoid arthritis	1.45e-06	6.82e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TYK2—rheumatoid arthritis	1.45e-06	6.81e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.43e-06	6.73e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	1.43e-06	6.71e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NOS3—rheumatoid arthritis	1.42e-06	6.69e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—IL6—rheumatoid arthritis	1.41e-06	6.64e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.41e-06	6.62e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FN1—rheumatoid arthritis	1.4e-06	6.58e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.39e-06	6.55e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—TGFB1—rheumatoid arthritis	1.38e-06	6.51e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—NFKB1—rheumatoid arthritis	1.36e-06	6.41e-06	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IL6—rheumatoid arthritis	1.36e-06	6.41e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MAPK8—rheumatoid arthritis	1.34e-06	6.3e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CD80—rheumatoid arthritis	1.34e-06	6.3e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.34e-06	6.3e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.33e-06	6.24e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.33e-06	6.24e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.31e-06	6.17e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.3e-06	6.11e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.29e-06	6.07e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL2—rheumatoid arthritis	1.28e-06	6.02e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—rheumatoid arthritis	1.27e-06	5.99e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CXCL8—rheumatoid arthritis	1.26e-06	5.93e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TP53—rheumatoid arthritis	1.26e-06	5.91e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CCL2—rheumatoid arthritis	1.25e-06	5.86e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6R—rheumatoid arthritis	1.24e-06	5.84e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL2—rheumatoid arthritis	1.24e-06	5.84e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—IL6—rheumatoid arthritis	1.24e-06	5.81e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MMP9—rheumatoid arthritis	1.21e-06	5.7e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL2—rheumatoid arthritis	1.21e-06	5.67e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.2e-06	5.64e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.19e-06	5.62e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.18e-06	5.54e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MMP9—rheumatoid arthritis	1.18e-06	5.53e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—IL6—rheumatoid arthritis	1.16e-06	5.47e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.16e-06	5.47e-06	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IL6—rheumatoid arthritis	1.15e-06	5.41e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.14e-06	5.38e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MMP9—rheumatoid arthritis	1.14e-06	5.36e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TYK2—rheumatoid arthritis	1.13e-06	5.32e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—IL6—rheumatoid arthritis	1.13e-06	5.31e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—NFKB1—rheumatoid arthritis	1.13e-06	5.31e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NOS3—rheumatoid arthritis	1.11e-06	5.22e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MAPK8—rheumatoid arthritis	1.11e-06	5.22e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.1e-06	5.17e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—IL6—rheumatoid arthritis	1.1e-06	5.15e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.09e-06	5.12e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TP53—rheumatoid arthritis	1.08e-06	5.08e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TP53—rheumatoid arthritis	1.06e-06	5e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.06e-06	4.97e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—TGFB1—rheumatoid arthritis	1.05e-06	4.93e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—IL6—rheumatoid arthritis	1.04e-06	4.9e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VEGFA—rheumatoid arthritis	1.02e-06	4.82e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TGFB1—rheumatoid arthritis	9.99e-07	4.7e-06	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IL6—rheumatoid arthritis	9.89e-07	4.65e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CXCL8—rheumatoid arthritis	9.85e-07	4.63e-06	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IL6—rheumatoid arthritis	9.73e-07	4.58e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TGFB1—rheumatoid arthritis	9.69e-07	4.56e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL2—rheumatoid arthritis	9.42e-07	4.43e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TGFB1—rheumatoid arthritis	9.4e-07	4.42e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—IL6—rheumatoid arthritis	9.37e-07	4.41e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	8.96e-07	4.21e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MMP9—rheumatoid arthritis	8.91e-07	4.19e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—NFKB1—rheumatoid arthritis	8.82e-07	4.15e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MAPK8—rheumatoid arthritis	8.67e-07	4.08e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—IL6—rheumatoid arthritis	8.56e-07	4.03e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TP53—rheumatoid arthritis	8.22e-07	3.87e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VEGFA—rheumatoid arthritis	8e-07	3.76e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TP53—rheumatoid arthritis	7.98e-07	3.75e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—IL6—rheumatoid arthritis	7.91e-07	3.72e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TP53—rheumatoid arthritis	7.74e-07	3.64e-06	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IL6—rheumatoid arthritis	7.52e-07	3.54e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TGFB1—rheumatoid arthritis	7.35e-07	3.45e-06	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IL6—rheumatoid arthritis	7.3e-07	3.43e-06	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IL6—rheumatoid arthritis	7.08e-07	3.33e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	6.45e-07	3.03e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TP53—rheumatoid arthritis	6.05e-07	2.84e-06	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IL6—rheumatoid arthritis	5.54e-07	2.6e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	5.38e-07	2.53e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	4.31e-07	2.02e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	3.93e-07	1.85e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	3.76e-07	1.77e-06	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	3.43e-07	1.62e-06	CbGpPWpGaD
